Fox Chase Cancer Center News

PHILADELPHIA (December 20, 2012)—By all accounts, a combination of colon cancer, diabetes and high blood pressure can be a recipe for medical disaster. Now, a new study led by a surgical oncologist and researcher at Temple University School of Medicine and Fox Chase Cancer Center has shown just how deadly this mix can be.

SAN ANTONIO, TX (December 8, 2012)—Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this type of cancer spreads, it's crucial to characterize the interactions between cancer cells and their 3D environment. Researchers at Fox Chase Cancer Center have developed a novel, 3D culture system that mimics the environment surrounding these cancer cells. This model could be used to test new anticancer drugs capable of inhibiting the spread of IBC tumors.

SAN ANTONIO, TX (December 7, 2012)—Blocking a specific protein renders tumors more vulnerable to treatment in mice, suggesting new therapies could eventually achieve the same in humans, according to new research from Fox Chase Cancer Center to be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium on Friday, December 7, 2012.

SAN ANTONIO, TX (December 7, 2012)—Previous research has shown that a family of genes, proteins and enzymes called the uPA system (for urokinase plasminogen activator) plays an active role in different facets of cancer's biology, including tumor cell invasion, the spread of metastases, and the growth of a primary tumor.

SAN ANTONIO, TX (December 6, 2012)—Women are more likely to follow experts' advice on how to reduce their risk of an important side effect of breast cancer surgery—like lymphedema—if they feel confident in their abilities and know how to manage stress, according to new research from Fox Chase Cancer Center to be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium on Saturday, December 8, 2012.

PHILADELPHIA, PA (December 3, 2012) – On March 1, 2013, leading cancer center administrator and nationally recognized hematology/oncology expert Richard I. Fisher, MD, will assume a set of vital leadership roles at Fox Chase Cancer Center, a member of the Temple University Health System, and Temple University School of Medicine.

PHILADELPHIA, PA (November 30, 2012)—Fox Chase Cancer Center will host the Third International Inflammatory Breast Cancer Conference on December 1-2, 2012, at the Sofitel Philadelphia (120 South 17th Street, Philadelphia).

The conference will focus on educating healthcare professionals and breast cancer advocates about inflammatory breast cancer (IBC)—a rare and very aggressive form of the disease that accounts for 1 to 5 percent of all breast cancers.

PHILADELPHIA, PA (November 15, 2012)—Fox Chase Cancer Center’s Board of Associates—a long standing group of volunteers who raise money for research and patient care through special projects and fundraising events—was named Outstanding Volunteer Fundraising Group of the Year by the Association of Fundraising Professionals-Greater Philadelphia Chapter (AFP-GPC).